Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126439901 | 12643990 | 1 | I | 20160624 | 20160802 | 20160811 | 20160811 | EXP | FR-PFIZER INC-2016371961 | PFIZER | 65.00 | YR | F | Y | 0.00000 | 20160811 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126439901 | 12643990 | 1 | PS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | CYCLE 1,FOR 2 DAYS EVERY 15 DAYS | U | 78813 | |||||||||
| 126439901 | 12643990 | 2 | SS | FLUOROURACILE ACCORD | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | CYCLE 1, FOR 2 DAYS EVERY 15 DAYS | U | 0 | |||||||||
| 126439901 | 12643990 | 3 | SS | IRINOTECAN ACCORD | IRINOTECAN | 1 | Intravenous (not otherwise specified) | CYCLE 1, FOR 2 DAYS EVERY 15 DAYS | U | 0 | |||||||||
| 126439901 | 12643990 | 4 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | 1 DF (8.4 MG/21 CM2), IN 72H | U | 0 | 1 | DF | |||||||
| 126439901 | 12643990 | 5 | SS | ABSTRAL | FENTANYL CITRATE | 1 | Sublingual | 100 UG, 4X/DAY | U | 0 | 100 | UG | SUBLINGUAL TABLET | QID | |||||
| 126439901 | 12643990 | 6 | SS | DUROGESIC | FENTANYL | 1 | Transdermal | 1 DF (2.1MG/5.25 CM2), IN 72H | U | 0 | 1 | DF | |||||||
| 126439901 | 12643990 | 7 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 1 G, 4X/DAY | U | 0 | 1 | G | QID | ||||||
| 126439901 | 12643990 | 8 | C | SPASFON /00765801/ | PHLOROGLUCINOL1,3,5-TRIMETHOXYBENZENE | 1 | UNK UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126439901 | 12643990 | 1 | Pancreatic carcinoma metastatic |
| 126439901 | 12643990 | 2 | Pancreatic carcinoma metastatic |
| 126439901 | 12643990 | 3 | Pancreatic carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126439901 | 12643990 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126439901 | 12643990 | Agranulocytosis | |
| 126439901 | 12643990 | Blood phosphorus decreased | |
| 126439901 | 12643990 | Hypokalaemia | |
| 126439901 | 12643990 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126439901 | 12643990 | 1 | 20160613 | 20160613 | 0 | |
| 126439901 | 12643990 | 2 | 20160613 | 20160613 | 0 | |
| 126439901 | 12643990 | 3 | 20160613 | 20160613 | 0 | |
| 126439901 | 12643990 | 4 | 201605 | 0 | ||
| 126439901 | 12643990 | 5 | 201605 | 0 | ||
| 126439901 | 12643990 | 6 | 20160613 | 0 | ||
| 126439901 | 12643990 | 7 | 20160613 | 0 |